A team of Johns Hopkins researchers is calling for magic mushrooms to be made legally available as medicine

A group of Johns Hopkins University scientists wrote in a recent journal article that psilocybin, the active ingredient in psychedelic magic mushrooms, has a low risk of harm and a high potential as a therapeutic drug. There’s been a resurgence of interest lately in psychedelics’ therapeutic potential for a variety of mental health applications, from depression to anxiety. Pending results from several ongoing clinical trials, the researchers called for psilocybin to be placed in

Continue reading...